"Pharmaceuticals" Main

Latest Morning Briefing Stories

Purity, Potency Of Illegal Drugs Have Reached New Levels, Worrying Health Officials

KHN Morning Briefing

The problem is that users aren’t expecting the higher strength drugs and are overdosing because of the increased potency of them. In other news on the crisis: addiction treatment, patients with chronic pain who desperately need opioids, an interview with the U.S. surgeon general, and opioid prescription practices.

Asia’s Bird Flu Putting Global Health Officials On High Alert

KHN Morning Briefing

The flu worries many scientists as they see it as the virus most likely to start a pandemic that kills millions, as the 1918 Spanish flu did. In other public health news: vaccines, blood pressure, cigarette ads, standing desks, napping on the job and more.

A Snapshot Of Those In The Trenches Of America’s Addiction Crisis

KHN Morning Briefing

The Associated Press puts human faces to the numbers behind the opioid epidemic. In other news, a look at how influence in Washington, D.C., has played a role in the crisis, Purdue wants to settle lawsuits with states, counterfeit pills are sending droves of people to the hospital, why medication-assisted treatment is hard for some to get, and more.

San Francisco Wages Quiet Battle Against Hep C With Patched-Together Budget, Determination

KHN Morning Briefing

The city’s campaign is the result of an alliance among health officials, hospitals, advocates, and clinicians to cobble together funding, coordinate care, and combat the stigma of a disease associated with prison, drug use, and unsafe sex. In other public health news: high blood pressure, immunotherapy, health health and sex, genetic engineering, and soda.

Big, Expensive Battle Brewing Between Pharma, Hospitals Over Drug Discount Program

KHN Morning Briefing

The 340B program requires drugmakers to offer discounts of up to 50 percent on medicines sold to safety net hospitals and health centers that serve low-income populations. The Trump administration wants to slash reimbursement payments to providers. Meanwhile, Vermont is investigating if pharmaceutical companies have violated state law by giving gifts or payments to providers.